Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0431A Protocol 170-04 in Type 2 Diabetes Mellitus
2011-002529-23Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sitagliptin + metformin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co. Primary endpoint: Primary endpoints (base study). Started Oct 2011; status: completed.
02
Drugs
sitagliptin + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-002529-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002529-23.